IPHARMA is a fast-growing innovative CRO in Russia and EAEU. Our pipeline consists of over 60 clinical trials in oncology, virology, endocrinology, neurology, transplantology, etc. We provide agile clinical services in both early-phase and registration trials, as well as medical, regulatory, and PV expertise to ensure optimal timeline for your drug development. According to Association of Clinical Trials Organizations, IPHARMA has been ranked as a market leader of Russian innovative drugs.